Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 01, 2026 10:52 ET | Source: Entreprises Minières Globex Inc.

Reprise des travaux de forage sur la propriété Berrigan zinc, or, argent sous option auprès de Mines indépendantes Chibougamau

TORONTO, 01 avr. 2026 (GLOBE NEWSWIRE) -- ENTREPRISES MINIÈRES GLOBEX INC. (GMX – Bourse de Toronto, G1MN – Bourses de Francfort, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS...
April 01, 2026 10:52 ET | Source: Globex Mining Enterprises Inc.

Drilling Resumes on Globex’s Berrigan Zinc, Gold, Silver Royalty Property NW of Chibougamau, Quebec

TORONTO, April 01, 2026 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS Exchange,...
April 01, 2026 09:57 ET | Source: Equity Insider

The Critical Metals No One Can Replace Are Running Out of Inventory

VANCOUVER, British Columbia, April 01, 2026 (GLOBE NEWSWIRE) -- EquityInsider.com Sector Commentary — Washington just committed another $500 million to domestic critical mineral processing[1]. That...
April 01, 2026 09:00 ET | Source: Oncolytics Biotech, Inc.

Oncolytics Biotech® Completes Domicile Change to the United States

SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today announced...
April 01, 2026 09:00 ET | Source: NeOnc Technologies Holdings, Inc.

NeOnc Provides Business Update and Reports Q4 2025 Financial Results

CALABASAS, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company developing...
April 01, 2026 08:30 ET | Source: Polaryx Therapeutics, Inc.

Polaryx Therapeutics To Participate In The 25th Annual Needham Virtual Healthcare Conference

PARAMUS, NJ, April 01, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics, Inc. (Nasdaq: PLYX), a clinical-stage biotechnology company developing novel, disease-modifying therapies for rare, pediatric...
April 01, 2026 08:02 ET | Source: Quantum BioPharma

Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis

TORONTO, April 01, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a...
April 01, 2026 08:00 ET | Source: Asia Broadband Inc.

GoldAxis Launches New Website, Highlighting Multiphase Expansion of Gold and Silver-Backed Digital Asset Platform

LAS VEGAS, April 01, 2026 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) today announced the official launch of GoldAxis wallet’s new website www.goldaxis.com,...
April 01, 2026 08:00 ET | Source: Cogent Biosciences, Inc.

Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST)

Bezuclastinib NDA submitted under the FDA’s RTOR program based on positive results from Phase 3 PEAK trial; bezuclastinib previously granted Breakthrough Therapy Designation in GISTBezuclastinib...
April 01, 2026 07:30 ET | Source: Medicus Pharma Ltd

Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset

PHILADELPHIA, April 01, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development...